Assessment of Antimicrobial Resistance and Virulence of Biofilm-Forming Uropathogenic Escherichia coli from Rio de Janeiro
<b>Background/Objectives:</b> Uropathogenic <i>Escherichia coli</i> (UPEC) is the leading cause of urinary tract infections in both community and hospital settings worldwide. Antimicrobial-resistant UPEC strains pose a significant challenge for effective antibiotic therapy. In this study, 50 bacterial isolates recovered from urine samples of patients attended in different sectors of a public hospital in Rio de Janeiro over five months were analyzed to assess antimicrobial resistance and virulence profiles through broad gene screening. <b>Methods:</b> Biofilm production was assessed using a semi-quantitative adherence assay. PCR was employed to investigate 27 resistance genes, 6 virulence genes, sequence types (STs), and phylogroups. Susceptibility to 25 antimicrobial agents was determined by disk diffusion testing. Furthermore, the pathogenic potential was evaluated <i>in vivo</i> using the <i>Tenebrio molitor</i> larvae infection model. <b>Results:</b> Most UPEC isolates were moderate or strong biofilm producers (41/50; 82%). The <i>sul1</i> and <i>sul2</i> resistance genes were the most frequently detected (58%). Two virulence gene patterns were identified: <i>fyuA</i>, <i>iutA</i>, <i>fimH</i>, <i>cnf1</i> and <i>fyuA</i>, <i>iutA</i>, <i>fimH</i> (13 isolates; 26%). ST131 and ST73 were the most common sequence types (16% each), and phylogroup B2 was the most prevalent (50%). Thirty isolates (60%) were multidrug-resistant, most of which belonged to phylogroup B2. UPEC exhibited dose-dependent lethality, causing 100% mortality at 2.6 × 10<sup>8</sup> CFU/mL within 24 h. <b>Conclusions:</b> These findings reinforce the urgent need for surveillance strategies and effective antimicrobial stewardship in clinical practice.
Authors
- Marinella Silva Laport (ORCID: https://orcid.org/0000-0001-5252-0671)
- Cláudia Rezende Vieira de Mendonça-Souza (ORCID: https://orcid.org/0000-0003-1941-7757)
- Alexander Machado Cardoso (ORCID: https://orcid.org/0000-0003-2974-0232)
- Manuela Oliveira (ORCID: https://orcid.org/0000-0002-3910-1525)
- Rubens Clayton da Silva Dias (ORCID: https://orcid.org/0000-0002-7928-4354)
- Samantha dos Santos Tufic-Garutti
- Thiago Pavoni Gomes Chagas (ORCID: https://orcid.org/0000-0001-5282-7112)
- Anna Luiza Bauer Canellas (ORCID: https://orcid.org/0000-0002-0572-9293)
- Danilo Freitas Rangel (ORCID: https://orcid.org/0000-0001-6974-0152)
- Jamila Alessandra Perini (ORCID: https://orcid.org/0000-0002-7683-0698)
- Lidiane Coelho Berbert (ORCID: https://orcid.org/0000-0002-4882-176X)
- Viviane Cristina Vieira da Silva (ORCID: https://orcid.org/0009-0003-3562-6230)
- Flávia Lúcia Piffano Costa Pellegrino (ORCID: https://orcid.org/0000-0003-0885-9728)
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Universidade Federal Fluminense (BR)
- Universidade do Estado do Rio de Janeiro (BR)
- Czech Academy of Sciences, Institute of Biophysics (CZ)
- Universidade Federal do Estado do Rio de Janeiro (BR)
Publication Details
- Journal
- Antibiotics
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3390/antibiotics14090869
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro